Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model

Journal of Magnetic Resonance Imaging

Volumn 8, Issue 4, 1998, Pages 799-806

  Ostrowitzki, Susanne ^a   Fick, James ^b   Roberts, Timothy P L ^a   Wendland, Michael F ^a   Aldape, Kenneth D ^a   Mann, Jeffry S ^a   Israel, Mark A ^b   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Comparative study; Dynamic MRI; Fractional blood volume; Malignant (9L) glioma; MR contrast agents; Quantitative microvascular permeability

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE ALBUMIN; GADOLINIUM PENTETATE MEGLUMINE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; CONTRAST ENHANCEMENT; GLIOMA; HISTOPATHOLOGY; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO;

ALBUMINS; ANIMALS; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; GADOLINIUM DTPA; GLIOMA; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; RATS; RATS, INBRED F344;

EID: 0031824357     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880080408     Document Type: Article

References (49)

1. Sage MR. Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. Am J Roentgenol 1982; 138: 887-898.
2. Dvorak H, Brown L, Detman M, Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
3. Scherrer H-J. Gliomstudien. III. Angioplastische gliome. Virchows Arch 1935; 294:823-861.
4. Zuelch K. Histological typing of tumors of the central nervous system. Geneva: World Health Organization, 1979.
5. Wiestler OD, Wolf HK. [Revised WHO classification and new developments in diagnosis of central nervous system tumors]. Pathologe 1995; 16:245-255.
6. Robinson P, Rapoport S. Model for drug uptake by brain tumors: effects of osmotic treatment and of diffusion in brain. J Cereb Blood Flow Metab 1989; 10:153-161.
7. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 87: 10931-10934.
8. Millauer B, Shawver L, Plate K, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994; 367:576-578.
9. Plate K, Risau W. Angiogenesis in malignant gliomas. Glia 1995; 15:339-347.
10. van Dijke C, Brasch R, Roberts T, et al. Mammary carcinoma model: correlation of macromolecular contrast enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996; 198:813-818.
11. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis correlates with metastasis in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
12. Schmiedl U, Kenney J, Maravilla K. MRI of blood-brain-barrier permeability in astrocytic gliomas: application of small and large molecular weight contrast media. Magn Reson Med 1991; 22:288-292.
13. Schmiedl U, Kenney J, Maravilla K. Kinetics of pathologic blood-brain-barrier permeability in an astrocytic glioma using contrast-enhanced MR. Am J Neuroradiol 1992; 13:5-14.
14. Brasch R, Berthezène Y, Vexler V, etal. Pulmonary oxygen toxicity: demonstration of abnormal capillary permeability using contrast-enhanced MRI. Pediatr Radiol 1993; 23:495-500.
15. Brasch R, Shames D, Cohen F, et al. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary carcinomas. Invest Radiol 1994; 29(suppl 2):S8-S11.
16. Cohen F, Kuwatsuru R, Shames D, et al. Contrast enhanced MRI estimation of altered capillary permeability in experimental mammary carcinomas following x-irradiation. Invest Radiol 1995; 29:970-977.
17. Kuwatsuru R, Liu T, Cohen F, et al. Acute liver transplant rejection: early detection of endothelial leak in a rat model using MRI and a macromolecular contrast medium. Invest Radiol 1994; 29:8297-8299.
18. Schwickert H, Roberts T, Shames D, et al. Quantification of liver blood volume: comparison of ULSTIR-EPI, a fast inversion recovery echo-planar approach, with dynamic 3D-SPGR. Magn Reson Med 1995; 34:845-852.
19. Schwickert H, Stiskal M, Roberts T, et al. Contrast-enhanced MRI assessment of tumor capillary permeability: the effect of pre-irradiation on the tumor delivery of chemotherapy. Radiology 1996; 198:893-898.
20. Barker M. Development of an animal brain tumor model and its response to therapy with 1,3-Bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1973; 33:976-986.
21. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987; 22:665-671 [published erratum appears in Invest Radiol 1988; 23(12):961].
22. Crone C. The permeability of capillaries in various organs determined by the use of the "indicator diffusion" method. Acta Physiol Scand 1963; 58:292-305.
23. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959; 197: 1205-1210.
24. Shames D, Kuwatsuru R, Vexler V, Muehler A, Brasch R. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique. Magn Reson Med 1993; 29:616-622.
25. Wedeking P, Eaton S, Covell DG, Nair S, Tweedle MF, Eckelman WC. Pharmacokinetic analysis of blood distribution of intravenously administered 153Gd-labeled Gd(DTPA)2- and 99mTc(DTPA) in rats. Magn Reson Imaging 1990; 8:567-575.
26. Greenberg JH, Alavi A, Reivich M, Kuhl D, Uzzell B. Local cerebral blood volume response to carbon dioxide in man. Circ Res 1978; 43:324-331.
27. Kuhl DE, Reivich M, Alavi A, Nyary I, Staum MM. Local cerebral blood volume determined by three-dimensional reconstruction of radionuclide scan data. Circ Res 1975; 36:610-619.
28. Eke A, Hutiray G, Kovach AG. Induced hemodilution detected by reflectometry for measuring microregional blood flow and blood volume in cat brain cortex. Am J Physiol 1979; 236:H759-H768.
29. Lu D, Joseph PM, Greenberg JH, Lin R, Mukherji B, Sloviter HA.. Use of 19F magnetic resonance im ging to measure local cerebral blood volume. Magn Reson Med 1993; 29:179-187.
30. Pawlik G, Rackl A, Bing RJ. Quantitative capillary topography and blood flow in the cerebral cortex of cats: an in vivo microscopic study. Brain Res 1981; 208:35-58.
31. White DL, Wang S-C, Roth K, Brasch RC, Dupon JW, Moseley ME. Determination of perfused cerebral blood volume using an intravascular MR contrast agent. In: Proceedings of the 8th annual scientific meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine, 1989; 806.
32. Brasch R, Pham C, Shames D, et al. Assessing tumor angiogenesis using macromolecular MRI contrast media. JMRI 1997; 7:68-74.
33. Schmiedl U, Ogan M, Paaianen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987; 162:205-210.
34. Fross RD, Warnke PC, Groothuis DR. Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research. J Neurooncol 1991; 11: 185-197.
35. Blasberg R, Molnar P, Groothius D, Patlak C, Owens E, Fenstermacher J. Concurrent measurements of blood flow and transcapillary transport in avian sarcoma virus-induced experimental brain tumors: implications for chemotherapy. J Pharmacol Exp Ther 1984; 231:724-735.
36. Arosarena O, Guerin C, Brem H, Laterra J. Endothelial differentiation in intracerebral and subcutaneous experimental gliomas. Brain Res 1994; 640:98-104.
37. Kim B, Chenevert T, Ross B. Growth kinetics and treatment response of the intracranial rat 9L brain tumor model: a quantitative in vivo study using magnetic resonance imaging. Clin Cancer Res 1995; 1:643-650.
38. Plate K, Breier G, Millauer B, Ullrich A, Risau W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993; 53:5822-5827.
39. Tofts P. Modelling tracer kinetics in dynamic Gd-DTPA MR imaging. JMRI 1997 (in press).
40. Schmiedl UP, Maravilla KR, Nelson JA. Improved method for in vivo magnetic resonance contrast media research. Invest Radiol 1991; 26:65-70.
41. Bloembergen N, Purcell EM, Pound RV. Principles of nuclear relaxation. Physiol Rev 1948; 73:679.
42. Donahue K, Burstein D, Manning W, Gray M. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994; 32:66-76.
43. Koenig SH, Spiller M, Brown III RD, Wolf GL. Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA). Magn Reson Med 1986; 3:791-795.
44. Strich G, Hagan P, Gerber K, Slutsky R. Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA. Radiology 1985; 154:723-726.
45. Boucher Y, Leunig M, Jain RK. Tumor angiogenesis and interstitial hypertension. Cancer Res 1996; 56:4264-4266.
46. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987; 47:3039-3051.
47. Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 1990; 50:814S-819S.
48. Strugar J, Rothbart D, Harrington W, Criscuolo GR. Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 1994; 81:560-566.
49. Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 1972; 48:347-356.